Taken together, the decreased FAT/CD36 and increased GLUT4 with cardiac hypertrophy resembles the decreased fatty acid metabolism and increased glucose metabolism measured in vivo[4], [5]. This evidence concerns the gene SLC2A4 and cardiac hypertrophy.